Every disease has its own medicine *
The BelACT therapy serves the treatment of arteriosclerosis, a disease that becomes more and more obvious with age. Arteriosclerosis describes a change in the blood vessels that is responsible for a large number of cardiovascular diseases and is therefore one of the main causes of premature death.
One cause is lipid and calcium deposits and increasing inflammatory processes as well as the loss of elasticity of the connective tissue. Arteriosclerosis is characterized by an increasing hardening of the entire vascular wall and the formation of atherosclerotic plaques on the inner walls of the arteries. This can lead to permanently increased blood pressure and, with increasing plaque formation, to a narrowing of the arterial flow path and impairment of the organ blood supply.
The basis of the therapy is a drug, which is produced by a genetic engineering procedure. To produce a similar active ingredient, complex processes and animal components are still necessary today. This medicine is administered intravenously to the human body. In more than 10 years, it has been proven that the combination of drugs and procedures makes it possible to reverse arteriosclerotic changes. Based on this knowledge, the basic principles for the planned drug are defined and documented for approval by the EMA.